Abhishek Paserkar։ Revolutionizing Hypertriglyceridemia Treatment With Olezarsen
Abhishek Paserkar, Medical Doctor, shared a post on LinkedIn:
՛՛Revolutionizing Hypertriglyceridemia Treatment!
Excited to dive into this groundbreaking review on Olezarsen (Tryngolza) – the next-gen GalNAc-conjugated antisense oligonucleotide targeting ApoC-III for severe hypertriglyceridemia and Familial Chylomicronemia Syndrome (FCS)!
Published in Cureus (Nov 2025) by Joshy et al., it highlights how olezarsen slashes triglycerides by ~60% in FCS patients over 12 months, dramatically cutting pancreatitis events (just 1 vs. 11 on placebo in BALANCE trial)!
Key Highlights
Mechanism Magic: Inhibits hepatic ApoC-III, boosting LPL-dependent and independent triglyceride clearance – even in LPL-deficient FCS!
Trial Triumphs: Phase 3 BALANCE: TG decreased 59%, ESSENCE: decreased 58-61% in moderate HTG + CV risk. Ongoing CORE trials target pancreatitis prevention in severe HTG.
Safety Superstar: Mild injection-site reactions only; no thrombocytopenia like older volanesorsen. Monthly 80mg SC dose – convenient and tolerable!
This precision therapy (FDA-approved Dec 2024) transforms management of life-threatening TG disorders, paving the way for CV risk reduction. A must-read for pharmacologists, endocrinologists and lipid experts! ՛՛
Stay updated with Hemostasis Today.
-
Mar 19, 2026, 18:29Rameez Ashraff: Have You Noticed Neutrophil Inclusions in a Thrombocytopenia Smear?
-
Mar 19, 2026, 18:07Leonardo Roever: A Consensus Framework for Biomarker Research and Clinical Translation in Stroke
-
Mar 19, 2026, 17:49Matteo Foschi: Breaktrough Stroke on Oral Anticoaugulants for Atrial Fibrillation
-
Mar 19, 2026, 17:30UK Haemophilia Society Continues to Empower Individuals and Families Through Advocacy, Education, and Community Support – WFH
-
Mar 19, 2026, 17:20Dimitrios Nikas: Stroke During TAVI Procedures Still Remains Noticeable High
-
Mar 19, 2026, 17:14Akinchan Bhardwaj: Differences in Bleeding Outcomes Among DOACs
-
Mar 19, 2026, 17:03How Personal Experiences Can Support Self‑Advocacy and Help Improve Healthcare Outcomes – Hemophilia Alliance
-
Mar 19, 2026, 16:54X. Long Zheng: Unpacking the Real-World Challenges of ADAMTS13 on ISTH Pulse Podcast
-
Mar 19, 2026, 16:50Zain Khalpey: Predictive Imaging and AI in Aortic Dissection Risk Assessment